A Clinical study to Evaluate the Safety and Efficacy of compound Unani formulation in the Management of Gastritis

An Open Labelled Randomised Active Controlled Clinical Study Of Iltihab Ul Meda Bis Sabab Wa Taseerul Muzirrat Bil Advia (Drug Induced Gastritis) With Compound Unani Formulation - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075176

Enrollment

Registered

2024-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K295- Unspecified chronic gastritis

Interventions

Intervention1: Sufoof-e-Vaj: Sufoof-e-Vaj 5 gm, BD, with water, before meals, for 60 days, with 4 follow ups at interval of 15 days Control Intervention1: Tab Pantoprazole 40mg : Tab Pantoprazole 40mg

Eligibility

Inclusion criteria

Inclusion criteria: Patient with following Complaints Of: 1. Epigastric Pain 2.Nausea 3.Vomiting 4.Indigestion 5.Heart Burn6. Loss of Appetite 6. Eructation Patient with Drug History of NSAIDS for more than 3months

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2. Patient with H.pylori 3.Uncontrolled hypertension and diabetes 4.Patients with: Active GI bleed Obstruction and perforation Gastric carcinoma 5.Previous h/o smoking and alcohol 6.Recent use of antibiotics 7.Patients with renal, cardiac, pulmonary and other systemic diseases

Design outcomes

Primary

Measure	Time frame
To diagnose te patient based oh LDQ scale (leeds Dyspepsia quesionnare) and symptomsTimepoint: once in 2 weeks	—

Secondary

Measure	Time frame
To prove / show the comparative study results in cases of Drug Induced GastritisTimepoint: once in 2 weeks	—

Countries

India

Contacts

Public ContactDr Shams Unnisa

Government Nizamia Tibbi College

drsakhussaini@gmail.com9704888561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026